Evidence map›Paper›PMID 33633225›Full record

ArticleScientific reports2021

rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitis.

Yuki Hitomi, Yoshihiro Aiba, Yosuke Kawai, Kaname Kojima, Kazuko Ueno, Nao Nishida, Minae Kawashima, Olivier Gervais, Seik-Soon Khor, Masao Nagasaki and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Possible causes of atherosclerosis: lncRNAAnnals of translational medicine · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Yuki HitomiDepartment of Microbiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. yhitomi-tky@umin.ac.jp.
Yoshihiro AibaClinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Omura, Japan.
Yosuke KawaiGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Kaname KojimaTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Kazuko UenoGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Nao NishidaGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Minae KawashimaJapan Science and Technology Agency (JST), Tokyo, Japan.
Olivier GervaisHuman Biosciences Unit for the Top Global Course Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan.
Seik-Soon KhorGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Masao NagasakiHuman Biosciences Unit for the Top Global Course Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan.
Katsushi TokunagaGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Minoru NakamuraClinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Omura, Japan.
Makoto TsuijiDepartment of Microbiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. m-tsuiji@hoshi.ac.jp.
National Center for Global Health and Medicine · JPKyoto University · JPEbara (Japan) · JPHoshi University · JPJapan Science and Technology Agency · JPNagasaki Medical Center · JPNagasaki University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary biliary cholangitis (PBC) is a chronic, progressive cholestatic liver disease in which intrahepatic bile ducts are destroyed by an autoimmune reaction. Our previous genome-wide association study (GWAS) identified chromosome 11q23.1 as a susceptibility gene locus for PBC in the Japanese population. Here, high-density association mapping based on single nucleotide polymorphism (SNP) imputation and in silico/in vitro functional analyses identified rs1944919 as the primary functional variant. Expression-quantitative trait loci analyses showed that the PBC susceptibility allele of rs1944919 was significantly associated with increased COLCA1/COLCA2 expression levels. Additionally, the effects of rs1944919 on COLCA1/COLCA2 expression levels were confirmed using genotype knock-in versions of cell lines constructed using the CRISPR/Cas9 system and differed between rs1944919-G/G clones and -T/T clones. To our knowledge, this is the first study to demonstrate the contribution of COLCA1/COLCA2 to PBC susceptibility.

Indexed as

AllelesChromosomes, Human, Pair 11Genetic Predisposition to DiseaseEpistasis, GeneticGene ExpressionGenetic Association StudiesGenetic VariationGenome-Wide Association StudyGenomicsHumansLiver Cirrhosis, BiliaryNeoplasm ProteinsPolymorphism, Single NucleotideRNACOLCA1 protein, humanNeoplasm ProteinsPOU2AF3 protein, humanRNA

Identifiers

PMID33633225
PMCPMC7907150
OpenAlexW3133135588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.